ATE396997T1 - Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel - Google Patents

Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Info

Publication number
ATE396997T1
ATE396997T1 AT06723254T AT06723254T ATE396997T1 AT E396997 T1 ATE396997 T1 AT E396997T1 AT 06723254 T AT06723254 T AT 06723254T AT 06723254 T AT06723254 T AT 06723254T AT E396997 T1 ATE396997 T1 AT E396997T1
Authority
AT
Austria
Prior art keywords
bizyclic
benzimidazoles
pyrrolidino
substituted
production
Prior art date
Application number
AT06723254T
Other languages
German (de)
English (en)
Inventor
Elisabeth Defossa
Karl Schoenafinger
Gerhard Jaehne
Christian Bunning
Georg Tschank
Ulrich Werner
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE396997T1 publication Critical patent/ATE396997T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06723254T 2005-03-19 2006-03-07 Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel ATE396997T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005012872A DE102005012872A1 (de) 2005-03-19 2005-03-19 Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE396997T1 true ATE396997T1 (de) 2008-06-15

Family

ID=36579682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06723254T ATE396997T1 (de) 2005-03-19 2006-03-07 Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Country Status (11)

Country Link
US (1) US7569700B2 (OSRAM)
EP (1) EP1863817B1 (OSRAM)
JP (1) JP2008533064A (OSRAM)
AT (1) ATE396997T1 (OSRAM)
AU (1) AU2006226637A1 (OSRAM)
BR (1) BRPI0608456A2 (OSRAM)
CA (1) CA2602229A1 (OSRAM)
DE (2) DE102005012872A1 (OSRAM)
IL (1) IL185805A0 (OSRAM)
MX (1) MX2007010841A (OSRAM)
WO (1) WO2006099940A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102260265B (zh) 2010-05-24 2015-09-02 上海阳帆医药科技有限公司 六氢吡咯[3,4-b]吡咯衍生物、其制备方法及其用途
TWI757266B (zh) * 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
KR20210125471A (ko) 2018-10-05 2021-10-18 안나푸르나 바이오, 인코포레이티드 Apj 수용체 활성과 관련된 병태를 치료하기 위한 화합물 및 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1122257B1 (en) * 2000-01-05 2005-10-12 Pfizer Inc. Benzimidazole compounds as ORL1-receptor agonists
JP4109111B2 (ja) * 2000-12-06 2008-07-02 エフ.ホフマン−ラ ロシュ アーゲー 縮合複素環式芳香族グルコキナーゼアクチベーター
US6855708B2 (en) * 2001-03-20 2005-02-15 Merck & Co., Inc. N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors
US7541477B2 (en) * 2002-07-30 2009-06-02 Banyu Pharmaceutical Co., Ltd. Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
ATE450533T1 (de) * 2003-02-14 2009-12-15 Glaxo Group Ltd Carboxamidderivate
WO2005035526A1 (en) * 2003-10-09 2005-04-21 Argenta Discovery Ltd. Bicyclic compounds and their therapeutic use

Also Published As

Publication number Publication date
MX2007010841A (es) 2007-11-09
CA2602229A1 (en) 2006-09-28
US20080090890A1 (en) 2008-04-17
WO2006099940A1 (de) 2006-09-28
AU2006226637A1 (en) 2006-09-28
BRPI0608456A2 (pt) 2010-01-05
IL185805A0 (en) 2008-01-06
EP1863817B1 (de) 2008-05-28
WO2006099940A8 (de) 2006-11-09
EP1863817A1 (de) 2007-12-12
US7569700B2 (en) 2009-08-04
JP2008533064A (ja) 2008-08-21
DE102005012872A1 (de) 2006-09-28
DE502006000850D1 (de) 2008-07-10

Similar Documents

Publication Publication Date Title
CY1125006T1 (el) Λιπαρα οξεα και η χρηση τους σε συνδυασμο με βιομορια
WO2008108958A3 (en) Benzimidazole derivatives and methods of use thereof
ECSP099375A (es) Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa
WO2005009398A3 (en) Tetracyclic benzamide derivatives and methods of use thereof
WO2008150486A3 (en) 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
NO20084919L (no) Oksadiazolidindionforbindelse
EA200970088A1 (ru) Модуляторы метаболизма и лечение связанных с ним нарушений
WO2009023718A3 (en) Novel activators of glucokinase
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
WO2008033460A3 (en) Treating pain, diabetes, and lipid metabolism disorders
NZ715983A (en) Vasoprotective and cardioprotective antidiabetic therapy
MX2010005186A (es) Tiazolopiridinas solubilizadas.
DE502006006107D1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TW200635878A (en) Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use
TW200505880A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
NO20054408L (no) 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose
NO20081681L (no) N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
WO2008111956A3 (en) Fatty acid oxidation inhibitors treating hyperglycemia and related disorders
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
WO2008035305A8 (en) Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
ATE396997T1 (de) Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2008039087A3 (en) Indoline derivatives and uses thereof
WO2007029121A3 (en) Novel cyclopent-2-en-1-one derivatives which are ppar receptor modulators, and use thereof in pharmaceutical or cosmetic compositions
EA201171368A1 (ru) Новые гетероциклические соединения

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee